• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Medical Properties Trust, Inc. Reports Fourth Quarter and Full-Year Results

    2/27/25 8:00:00 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate
    Get the next $MPW alert in real time by email

    Completed Approximately $5.5 Billion of Asset Monetization Transactions, Including February's $2.5 Billion Senior Secured Notes Offering That Addresses All Debt Maturities Through 2026

    Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced financial and operating results for the fourth quarter and full-year ended December 31, 2024, as well as certain events occurring subsequent to quarter end.

    • Net loss of ($0.69) and Normalized Funds from Operations ("NFFO") of $0.18 for the 2024 fourth quarter and net loss of ($4.02) and NFFO of $0.80 for the full-year 2024, all on a per share basis. Fourth quarter 2024 net loss includes approximately $415 million ($0.69 per share) in impairments and fair market value adjustments related to Prospect Medical Group ("Prospect") and PHP Holdings ("PHP");
    • Completed a well-oversubscribed private offering of more than $2.5 billion of senior secured notes due in 2032 at a blended coupon rate of 7.885%, the proceeds from which will repay all debt maturities until October 2026 and result in expected combined cash and line of credit availability of $1.4 billion;
    • Simultaneous to the senior secured notes offering, the Company amended its line of credit to share collateral with the new senior secured notes and received universal affirmation of the long-standing banking group's approximate $1.5 billion commitment with a fully extended (at MPT's option) maturity in June 2027;
    • Commenced rent during the fourth quarter on a $50 million building improvement project in Idaho Falls, Idaho;
    • Sold two post-acute properties and agreed to sell an additional general acute facility during January for combined proceeds of approximately $45 million; and
    • Declared a regular quarterly dividend of $0.08 per share in February.

    Edward K. Aldag, Jr., Chairman, President and Chief Executive Officer, said, "We delivered on exactly what we said we would do in 2024 by using proceeds from transactions to accelerate repayment of debt maturities. Our global real estate portfolio remains attractive to sophisticated investors, as evidenced by our recent five-and-a-half times oversubscribed secured notes transaction. We improved the operator diversification of our portfolio and effectively addressed all debt maturities through 2026, positioning MPT to pursue a range of shareholder value initiatives in 2025."

    Included in the financial tables accompanying this press release is information about the Company's assets and liabilities, operating results, and reconciliations of net (loss) income to NFFO, including per share amounts, all on a basis comparable to 2023 results.

    PORTFOLIO UPDATE

    Medical Properties Trust has total assets of approximately $14.3 billion, including $8.6 billion of general acute facilities, $2.4 billion of behavioral health facilities and $1.6 billion of post-acute facilities. As of December 31, 2024, MPT's portfolio included 396 properties and approximately 39,000 licensed beds leased to or mortgaged by 53 hospital operating companies across the United States as well as in the United Kingdom, Switzerland, Germany, Spain, Finland, Colombia, Italy and Portugal.

    Hospitals around Europe are benefiting from strong reimbursement trends, growing occupancy, and higher acuity levels. In the United Kingdom, private medical insurance utilization has reached an all-time high – enabling operators such as Circle Health to deliver strong financial performance driven by volume growth as increasingly complex cases are being addressed in the private sector.

    In the United States, hospital fundamentals continue to broadly improve across the general acute segment as increasing admissions and growing surgical volumes are driving improved coverage. In the behavioral and post-acute segments, operators are reporting consistent growth in inpatient admissions as well as improvements in contract labor costs.

    Following the first full quarter of operations since transitioning 15 hospitals to new operators in September, MPT is encouraged by performance trends being reported across this portfolio as well as by a fifth tenant who leased two additional facilities in November. Across this footprint, our tenants have reported improving volumes, increasing patient satisfaction, and stabilization of staffing and supplies.

    In January, Prospect Medical Group commenced an in-court restructuring process under Chapter 11 of the U.S. Bankruptcy Code. In February, MPT entered into a Term Sheet providing for a settlement that will enable Prospect to sell its hospitals and the related real estate with MPT's cooperation. This settlement is subject to Bankruptcy Court approval.

    OPERATING RESULTS

    Net loss for the fourth quarter and year ended December 31, 2024 was ($413 million) (($0.69) per share) and ($2.4 billion) (($4.02) per share), respectively, compared to net loss of ($664 million) (($1.11) per share) and net loss of ($556 million) (($0.93) per share) in the year earlier periods. Net loss for the quarter ended December 31, 2024 included, among other non-recurring items, approximately $415 million of impairments and fair market value adjustments related to Prospect and PHP.

    NFFO for the fourth quarter and year ended December 31, 2024 was $108 million ($0.18 per share) and $483 million ($0.80 per share), respectively, compared to $218 million ($0.36 per share) and $951 million ($1.59 per share) in the year earlier periods.

    CONFERENCE CALL AND WEBCAST

    The Company has scheduled a conference call and webcast for February 27, 2025 at 11:00 a.m. Eastern Time to present the Company's financial and operating results for the quarter and year ended December 31, 2024. The dial-in numbers for the conference call are 877-883-0383 (U.S.) and 412-902-6506 (International) along with passcode 9974897. The conference call will also be available via webcast in the Investor Relations section of the Company's website, www.medicalpropertiestrust.com.

    A telephone and webcast replay of the call will be available beginning shortly after the call's completion. The telephone replay will be available through March 13, 2025, using dial-in numbers 877-344-7529 (U.S.), 855-669-9658 (Canada) and 412-317-0088 (International) along with passcode 1210933. The webcast replay will be available for one year following the call's completion on the Investor Relations section of the Company's website.

    The Company's supplemental information package for the current period will also be available on the Company's website in the Investor Relations section.

    The Company uses, and intends to continue to use, the Investor Relations page of its website, which can be found at www.medicalpropertiestrust.com, as a means of disclosing material nonpublic information and of complying with its disclosure obligations under Regulation FD, including, without limitation, through the posting of investor presentations that may include material nonpublic information. Accordingly, investors should monitor the Investor Relations page, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

    About Medical Properties Trust, Inc.

    Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 396 facilities and approximately 39,000 licensed beds in nine countries and across three continents as of December 31, 2024. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. For more information, please visit the Company's website at www.medicalpropertiestrust.com.

    Forward-Looking Statements

    This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use of forward-looking words such as "may", "will", "would", "could", "expect", "intend", "plan", "estimate", "target", "anticipate", "believe", "objectives", "outlook", "guidance" or other similar words, and include statements regarding our strategies, objectives, asset sales and other liquidity transactions (including the use of proceeds thereof), expected re-tenanting of facilities and any related regulatory approvals, and expected outcomes from Prospect's Chapter 11 restructuring process. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results or future events to differ materially from those expressed in or underlying such forward-looking statements, including, but not limited to: (i) the risk that the outcome and terms of the bankruptcy restructuring of Prospect will not be consistent with those anticipated by the Company; (ii) our success in implementing our business strategy and our ability to identify, underwrite, finance, consummate and integrate acquisitions and investments; (iii) the risk that previously announced or contemplated property sales, loan repayments, and other capital recycling transactions do not occur as anticipated or at all; (iv) the risk that MPT is not able to attain its leverage, liquidity and cost of capital objectives within a reasonable time period or at all; (v) MPT's ability to obtain or modify the terms of debt financing on attractive terms or at all, as a result of changes in interest rates and other factors, which may adversely impact its ability to pay down, refinance, restructure or extend its indebtedness as it becomes due, or pursue acquisition and development opportunities; (vi) the ability of our tenants, operators and borrowers to satisfy their obligations under their respective contractual arrangements with us; (vii) the ability of our tenants and operators to operate profitably and generate positive cash flow, remain solvent, comply with applicable laws, rules and regulations in the operation of our properties, to deliver high-quality services, to attract and retain qualified personnel and to attract patients; (viii) the risk that we are unable to monetize our investments in certain tenants at full value within a reasonable time period or at all; and (ix) the risks and uncertainties of litigation or other regulatory proceedings.

    The risks described above are not exhaustive and additional factors could adversely affect our business and financial performance, including the risk factors discussed under the section captioned "Risk Factors" in our Annual Report on Form 10-Ks and our Form 10-Qs, and as may be updated in our other filings with the SEC. Forward-looking statements are inherently uncertain and actual performance or outcomes may vary materially from any forward-looking statements and the assumptions on which those statements are based. Readers are cautioned to not place undue reliance on forward-looking statements as predictions of future events. We disclaim any responsibility to update such forward-looking statements, which speak only as of the date on which they were made.

    MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
     
    Consolidated Balance Sheets
    (Amounts in thousands, except for per share data)
    December 31, 2024 December 31, 2023
    Assets (Unaudited) (A)
    Real estate assets
    Land, buildings and improvements, intangible lease assets, and other

    $

    11,259,842

     

    $

    13,237,187

     

    Investment in financing leases

     

    1,057,770

     

     

    1,231,630

     

    Real estate held for sale

     

    34,019

     

     

    -

     

    Mortgage loans

     

    119,912

     

     

    309,315

     

    Gross investment in real estate assets

     

    12,471,543

     

     

    14,778,132

     

    Accumulated depreciation and amortization

     

    (1,422,948

    )

     

    (1,407,971

    )

    Net investment in real estate assets

     

    11,048,595

     

     

    13,370,161

     

     
    Cash and cash equivalents

     

    332,335

     

     

    250,016

     

    Interest and rent receivables

     

    36,327

     

     

    45,059

     

    Straight-line rent receivables

     

    700,783

     

     

    635,987

     

    Investments in unconsolidated real estate joint ventures

     

    1,156,397

     

     

    1,474,455

     

    Investments in unconsolidated operating entities

     

    439,578

     

     

    1,778,640

     

    Other loans

     

    109,175

     

     

    292,615

     

    Other assets

     

    471,404

     

     

    457,911

     

    Total Assets

    $

    14,294,594

     

    $

    18,304,844

     

     
    Liabilities and Equity
    Liabilities
    Debt, net

    $

    8,848,112

     

    $

    10,064,236

     

    Accounts payable and accrued expenses

     

    454,209

     

     

    412,178

     

    Deferred revenue

     

    29,445

     

     

    37,962

     

    Obligations to tenants and other lease liabilities

     

    129,045

     

     

    156,603

     

    Total Liabilities

     

    9,460,811

     

     

    10,670,979

     

     
    Equity
    Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares
    outstanding

     

    -

     

     

    -

     

    Common stock, $0.001 par value. Authorized 750,000 shares; issued and
    outstanding - 600,403 shares at December 31, 2024 and 598,991

     

     

     

     

    shares at December 31, 2023

     

    600

     

    599

    Additional paid-in capital

     

    8,584,917

     

     

    8,560,309

     

    Retained deficit

     

    (3,658,516

    )

     

    (971,809

    )

    Accumulated other comprehensive (loss) income

     

    (94,272

    )

     

    42,501

     

    Total Medical Properties Trust, Inc. Stockholders' Equity

     

    4,832,729

     

     

    7,631,600

     

     
    Non-controlling interests

     

    1,054

     

     

    2,265

     

    Total Equity

     

    4,833,783

     

     

    7,633,865

     

    Total Liabilities and Equity

    $

    14,294,594

     

    $

    18,304,844

     

     
    (A) Financials have been derived from the prior year audited financial statements.
    MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
     
    Consolidated Statements of Income
    (Unaudited)
     
    (Amounts in thousands, except for per share data) For the Three Months Ended For the Twelve Months Ended
    December 31, 2024 December 31, 2023 December 31, 2024 December 31, 2023
     
    Revenues
    Rent billed

    $

    166,965

     

    $

    78,421

     

    $

    719,749

     

    $

    803,375

     

    Straight-line rent

     

    43,695

     

     

    (166,769

    )

     

    163,414

     

     

    (127,894

    )

    Income from financing leases

     

    9,819

     

     

    19,412

     

     

    63,651

     

     

    127,141

     

    Interest and other income

     

    11,365

     

     

    (53,447

    )

     

    48,733

     

     

    69,177

     

    Total revenues

     

    231,844

     

     

    (122,383

    )

     

    995,547

     

     

    871,799

     

     
    Expenses
    Interest

     

    101,466

     

     

    102,338

     

     

    417,824

     

     

    411,171

     

    Real estate depreciation and amortization

     

    64,956

     

     

    77,295

     

     

    447,657

     

     

    603,360

     

    Property-related (A)

     

    9,780

     

     

    3,298

     

     

    27,255

     

     

    41,567

     

    General and administrative

     

    28,489

     

     

    30,150

     

     

    133,789

     

     

    145,588

     

    Total expenses

     

    204,691

     

     

    213,081

     

     

    1,026,525

     

     

    1,201,686

     

     
    Other (expense) income
    Gain (loss) on sale of real estate

     

    3,497

     

     

    (2,024

    )

     

    478,693

     

     

    (1,815

    )

    Real estate and other impairment charges, net

     

    (386,973

    )

     

    (283,619

    )

     

    (1,825,402

    )

     

    (376,907

    )

    Earnings (loss) from equity interests

     

    2,923

     

     

    (20,873

    )

     

    (366,642

    )

     

    13,967

     

    Debt refinancing and unutilized financing (costs) benefit

     

    (615

    )

     

    239

     

     

    (4,292

    )

     

    285

     

    Other (including fair value adjustments on securities)

     

    (48,744

    )

     

    (17,861

    )

     

    (615,565

    )

     

    7,586

     

    Total other expense

     

    (429,912

    )

     

    (324,138

    )

     

    (2,333,208

    )

     

    (356,884

    )

     
    Loss before income tax

     

    (402,759

    )

     

    (659,602

    )

     

    (2,364,186

    )

     

    (686,771

    )

     
    Income tax (expense) benefit

     

    (9,563

    )

     

    (3,982

    )

     

    (44,101

    )

     

    130,679

     

     
    Net loss

     

    (412,322

    )

     

    (663,584

    )

     

    (2,408,287

    )

     

    (556,092

    )

    Net income attributable to non-controlling interests

     

    (526

    )

     

    (359

    )

     

    (1,984

    )

     

    (384

    )

    Net loss attributable to MPT common stockholders

    $

    (412,848

    )

    $

    (663,943

    )

    $

    (2,410,271

    )

    $

    (556,476

    )

     
    Earnings per common share - basic and diluted:
    Net loss attributable to MPT common stockholders

    $

    (0.69

    )

    $

    (1.11

    )

    $

    (4.02

    )

    $

    (0.93

    )

     
    Weighted average shares outstanding - basic

     

    600,402

     

     

    598,984

     

     

    600,248

     

     

    598,518

     

    Weighted average shares outstanding - diluted

     

    600,402

     

     

    598,984

     

     

    600,248

     

     

    598,518

     

     
    Dividends declared per common share

    $

    0.08

     

    $

    0.15

     

    $

    0.46

     

    $

    0.88

     

     
    (A) Includes $3.9 million and $0.7 million of ground lease and other expenses (such as property taxes and insurance) paid directly by us and reimbursed by our tenants for the three months ended December 31, 2024 and 2023, respectively, and $13.7 million and $29.3 million for the twelve months ended December 31, 2024 and 2023, respectively.
    MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
           
    Reconciliation of Net (Loss) Income to Funds From Operations
    (Unaudited)
           
    (Amounts in thousands, except for per share data) For the Three Months Ended   For the Twelve Months Ended
    December 31, 2024   December 31, 2023   December 31, 2024   December 31, 2023
           
    FFO information:      
    Net loss attributable to MPT common stockholders

    $

    (412,848

    )

     

    $

    (663,943

    )

     

    $

    (2,410,271

    )

     

    $

    (556,476

    )

    Participating securities' share in earnings

     

    (139

    )

     

     

    (349

    )

     

     

    (946

    )

     

     

    (1,644

    )

    Net loss, less participating securities' share in earnings

    $

    (412,987

    )

     

    $

    (664,292

    )

     

    $

    (2,411,217

    )

     

    $

    (558,120

    )

           
    Depreciation and amortization

     

    79,396

     

     

     

    95,648

     

     

     

    509,524

     

     

     

    676,132

     

    (Gain) loss on sale of real estate

     

    (3,497

    )

     

     

    2,024

     

     

     

    (478,693

    )

     

     

    1,815

     

    Real estate impairment charges

     

    300,987

     

     

     

    112,112

     

     

     

    980,263

     

     

     

    167,966

     

    Funds from operations

    $

    (36,101

    )

     

    $

    (454,508

    )

     

    $

    (1,400,123

    )

     

    $

    287,793

     

           
    Write-off of billed and unbilled rent and other

     

    (332

    )

     

     

    499,335

     

     

     

    2,514

     

     

     

    649,911

     

    Other impairment charges, net

     

    85,986

     

     

     

    171,507

     

     

     

    1,255,929

     

     

     

    208,941

     

    Litigation and other

     

    4,801

     

     

     

    2,899

     

     

     

    51,308

     

     

     

    15,886

     

    Share-based compensation adjustments

     

    -

     

     

     

    (6,571

    )

     

     

    -

     

     

     

    (9,691

    )

    Non-cash fair value adjustments

     

    52,194

     

     

     

    8,405

     

     

     

    563,666

     

     

     

    (34,157

    )

    Tax rate changes and other

     

    523

     

     

     

    (2,797

    )

     

     

    5,119

     

     

     

    (167,332

    )

    Debt refinancing and unutilized financing costs (benefit)

     

    615

     

     

     

    (239

    )

     

     

    4,292

     

     

     

    (285

    )

    Normalized funds from operations

    $

    107,686

     

     

    $

    218,031

     

     

    $

    482,705

     

     

    $

    951,066

     

           
    Certain non-cash and related recovery information:      
    Share-based compensation

    $

    2,321

     

     

    $

    10,102

     

     

    $

    32,902

     

     

    $

    42,941

     

    Debt costs amortization

    $

    5,292

     

     

    $

    4,933

     

     

    $

    20,061

     

     

    $

    20,273

     

    Non-cash rent and interest revenue (A)

    $

    -

     

     

    $

    (57,920

    )

     

    $

    -

     

     

    $

    (239,599

    )

    Cash recoveries of non-cash rent and interest revenue (B)

    $

    542

     

     

    $

    2,364

     

     

    $

    7,382

     

     

    $

    38,451

     

    Straight-line rent revenue from operating and finance leases

    $

    (48,627

    )

     

    $

    (63,282

    )

     

    $

    (178,022

    )

     

    $

    (247,699

    )

           
           
    Per diluted share data:      
    Net loss, less participating securities' share in earnings

    $

    (0.69

    )

     

    $

    (1.11

    )

     

    $

    (4.02

    )

     

    $

    (0.93

    )

    Depreciation and amortization

     

    0.14

     

     

     

    0.16

     

     

     

    0.86

     

     

     

    1.13

     

    (Gain) loss on sale of real estate

     

    (0.01

    )

     

     

    -

     

     

     

    (0.80

    )

     

     

    -

     

    Real estate impairment charges

     

    0.50

     

     

     

    0.19

     

     

     

    1.63

     

     

     

    0.28

     

    Funds from operations

    $

    (0.06

    )

     

    $

    (0.76

    )

     

    $

    (2.33

    )

     

    $

    0.48

     

           
    Write-off of billed and unbilled rent and other

     

    -

     

     

     

    0.83

     

     

     

    -

     

     

     

    1.09

     

    Other impairment charges, net

     

    0.14

     

     

     

    0.29

     

     

     

    2.08

     

     

     

    0.35

     

    Litigation and other

     

    0.01

     

     

     

    -

     

     

     

    0.09

     

     

     

    0.03

     

    Share-based compensation adjustments

     

    -

     

     

     

    (0.01

    )

     

     

    -

     

     

     

    (0.02

    )

    Non-cash fair value adjustments

     

    0.09

     

     

     

    0.01

     

     

     

    0.94

     

     

     

    (0.06

    )

    Tax rate changes and other

     

    -

     

     

     

    -

     

     

     

    0.01

     

     

     

    (0.28

    )

    Debt refinancing and unutilized financing costs (benefit)

     

    -

     

     

     

    -

     

     

     

    0.01

     

     

     

    -

     

    Normalized funds from operations

    $

    0.18

     

     

    $

    0.36

     

     

    $

    0.80

     

     

    $

    1.59

     

           
    Certain non-cash and related recovery information:      
    Share-based compensation

    $

    -

     

     

    $

    0.02

     

     

    $

    0.05

     

     

    $

    0.07

     

    Debt costs amortization

    $

    0.01

     

     

    $

    0.01

     

     

    $

    0.03

     

     

    $

    0.03

     

    Non-cash rent and interest revenue (A)

    $

    -

     

     

    $

    (0.10

    )

     

    $

    -

     

     

    $

    (0.40

    )

    Cash recoveries of non-cash rent and interest revenue (B)

    $

    -

     

     

    $

    -

     

     

    $

    0.01

     

     

    $

    0.06

     

    Straight-line rent revenue from operating and finance leases

    $

    (0.08

    )

     

    $

    (0.11

    )

     

    $

    (0.30

    )

     

    $

    (0.41

    )

    Notes:

    Investors and analysts following the real estate industry utilize funds from operations ("FFO") as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or Nareit, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization, including amortization related to in-place lease intangibles, and after adjustments for unconsolidated partnerships and joint ventures.

    In addition to presenting FFO in accordance with the Nareit definition, we disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs (if any not paid by our tenants) to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our results of operations or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.

    Certain line items above (such as depreciation and amortization) include our share of such income/expense from unconsolidated joint ventures. These amounts are included with all activity of our equity interests in the "Earnings (loss) from equity interests" line on the consolidated statements of income.

    (A) Includes revenue accrued during the period but not received in cash, such as deferred rent, payment-in-kind ("PIK") interest or other accruals.

    (B) Includes cash received to satisfy previously accrued non-cash revenue, such as the cash receipt of previously deferred rent or PIK interest.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250226322304/en/

    Drew Babin, CFA, CMA

    Head of Financial Strategy and Investor Relations

    Medical Properties Trust, Inc.

    (646) 884-9809

    [email protected]

    Get the next $MPW alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MPW

    DatePrice TargetRatingAnalyst
    3/12/2025$5.00 → $9.00Neutral → Outperform
    Exane BNP Paribas
    9/13/2024$6.50Neutral → Buy
    Colliers Securities
    7/2/2024$4.00Outperform → Neutral
    Exane BNP Paribas
    4/17/2024$5.00Sell → Hold
    Deutsche Bank
    4/10/2024$10.00 → $4.25Buy → Neutral
    Colliers Securities
    3/1/2024$6.00Neutral → Outperform
    Exane BNP Paribas
    1/30/2024$2.00Sell
    Deutsche Bank
    1/5/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $MPW
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Medical Properties Trust, Inc. Reports First Quarter Results

      Results Consistent with Expectations Following Mid-Quarter Debt Refinancing Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced financial and operating results for the first quarter ended March 31, 2025, as well as certain events occurring subsequent to quarter end. Net loss of ($0.20) and Normalized Funds from Operations ("NFFO") of $0.14 for the 2025 first quarter on a per share basis. First quarter net loss includes approximately $73 million ($0.12 per share) in impairments and fair market value adjustments related to Prospect Medical Group ("Prospect") and PHP Holdings ("PHP"); Realized a 2.3% weighted average year-over-year inflation-based rent escal

      5/1/25 8:00:00 AM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate
    • Medical Properties Trust, Inc. Announces First Quarter 2025 Financial Results Conference Call and Webcast

      Medical Properties Trust, Inc. (NYSE:MPW) today announced it will host a conference call and webcast on Thursday, May 1, 2025 at 11:00 a.m. Eastern Time to discuss the company's first quarter 2025 financial results. A press release with first quarter 2025 financial results will be issued before the market opens on May 1, 2025. The dial-in numbers for the conference call are 800-715-9871 (North America) and 646-307-1963 (International) and the passcode to join the conference is 5278552. The conference call will also be webcast live on the Investor Relations section of the company's website, www.medicalpropertiestrust.com. A telephone and webcast replay of the call will be available shortly

      4/24/25 8:30:00 AM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate
    • Medical Properties Trust, Inc. Reports Fourth Quarter and Full-Year Results

      Completed Approximately $5.5 Billion of Asset Monetization Transactions, Including February's $2.5 Billion Senior Secured Notes Offering That Addresses All Debt Maturities Through 2026 Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced financial and operating results for the fourth quarter and full-year ended December 31, 2024, as well as certain events occurring subsequent to quarter end. Net loss of ($0.69) and Normalized Funds from Operations ("NFFO") of $0.18 for the 2024 fourth quarter and net loss of ($4.02) and NFFO of $0.80 for the full-year 2024, all on a per share basis. Fourth quarter 2024 net loss includes approximately $415 million ($0.69 pe

      2/27/25 8:00:00 AM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate

    $MPW
    SEC Filings

    See more
    • SEC Form DEFA14A filed by Medical Properties Trust Inc.

      DEFA14A - MEDICAL PROPERTIES TRUST INC (0001287865) (Filer)

      5/20/25 6:33:23 AM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate
    • SEC Form 8-K filed by Medical Properties Trust Inc.

      8-K - MEDICAL PROPERTIES TRUST INC (0001287865) (Filer)

      5/1/25 8:54:06 AM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate
    • Amendment: SEC Form SCHEDULE 13G/A filed by Medical Properties Trust Inc.

      SCHEDULE 13G/A - MEDICAL PROPERTIES TRUST INC (0001287865) (Subject)

      4/30/25 11:09:28 AM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate

    $MPW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Medical Properties Trust Inc.

      SC 13G - MEDICAL PROPERTIES TRUST INC (0001287865) (Subject)

      10/24/24 11:30:20 AM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G/A filed by Medical Properties Trust Inc. (Amendment)

      SC 13G/A - MEDICAL PROPERTIES TRUST INC (0001287865) (Subject)

      1/30/24 11:16:19 AM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G/A filed by Medical Properties Trust Inc. (Amendment)

      SC 13G/A - MEDICAL PROPERTIES TRUST INC (0001287865) (Subject)

      2/3/23 12:23:07 PM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate

    $MPW
    Financials

    Live finance-specific insights

    See more
    • Medical Properties Trust, Inc. Reports First Quarter Results

      Results Consistent with Expectations Following Mid-Quarter Debt Refinancing Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced financial and operating results for the first quarter ended March 31, 2025, as well as certain events occurring subsequent to quarter end. Net loss of ($0.20) and Normalized Funds from Operations ("NFFO") of $0.14 for the 2025 first quarter on a per share basis. First quarter net loss includes approximately $73 million ($0.12 per share) in impairments and fair market value adjustments related to Prospect Medical Group ("Prospect") and PHP Holdings ("PHP"); Realized a 2.3% weighted average year-over-year inflation-based rent escal

      5/1/25 8:00:00 AM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate
    • Medical Properties Trust, Inc. Announces First Quarter 2025 Financial Results Conference Call and Webcast

      Medical Properties Trust, Inc. (NYSE:MPW) today announced it will host a conference call and webcast on Thursday, May 1, 2025 at 11:00 a.m. Eastern Time to discuss the company's first quarter 2025 financial results. A press release with first quarter 2025 financial results will be issued before the market opens on May 1, 2025. The dial-in numbers for the conference call are 800-715-9871 (North America) and 646-307-1963 (International) and the passcode to join the conference is 5278552. The conference call will also be webcast live on the Investor Relations section of the company's website, www.medicalpropertiestrust.com. A telephone and webcast replay of the call will be available shortly

      4/24/25 8:30:00 AM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate
    • Medical Properties Trust, Inc. Reports Fourth Quarter and Full-Year Results

      Completed Approximately $5.5 Billion of Asset Monetization Transactions, Including February's $2.5 Billion Senior Secured Notes Offering That Addresses All Debt Maturities Through 2026 Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced financial and operating results for the fourth quarter and full-year ended December 31, 2024, as well as certain events occurring subsequent to quarter end. Net loss of ($0.69) and Normalized Funds from Operations ("NFFO") of $0.18 for the 2024 fourth quarter and net loss of ($4.02) and NFFO of $0.80 for the full-year 2024, all on a per share basis. Fourth quarter 2024 net loss includes approximately $415 million ($0.69 pe

      2/27/25 8:00:00 AM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate

    $MPW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Medical Properties Trust upgraded by Exane BNP Paribas with a new price target

      Exane BNP Paribas upgraded Medical Properties Trust from Neutral to Outperform and set a new price target of $9.00 from $5.00 previously

      3/12/25 7:29:27 AM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate
    • Medical Properties Trust upgraded by Colliers Securities with a new price target

      Colliers Securities upgraded Medical Properties Trust from Neutral to Buy and set a new price target of $6.50

      9/13/24 7:35:27 AM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate
    • Medical Properties Trust downgraded by Exane BNP Paribas with a new price target

      Exane BNP Paribas downgraded Medical Properties Trust from Outperform to Neutral and set a new price target of $4.00

      7/2/24 7:49:27 AM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate

    $MPW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Stewart Michael G sold $150,800 worth of shares (29,000 units at $5.20), decreasing direct ownership by 12% to 216,100 units (SEC Form 4)

      4 - MEDICAL PROPERTIES TRUST INC (0001287865) (Issuer)

      5/5/25 6:43:49 PM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate
    • SVP of Operations Hooper Rosa Handley covered exercise/tax liability with 368 shares, decreasing direct ownership by 0.11% to 349,421 units (SEC Form 4)

      4 - MEDICAL PROPERTIES TRUST INC (0001287865) (Issuer)

      4/17/25 6:00:13 PM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate
    • Executive Vice President & CFO Hamner R Steven covered exercise/tax liability with 5,584 shares and was granted 494,026 shares, increasing direct ownership by 19% to 3,023,989 units (SEC Form 4)

      4 - MEDICAL PROPERTIES TRUST INC (0001287865) (Issuer)

      4/17/25 6:00:07 PM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate

    $MPW
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Senior VP, Controller & CAO Hanna James Kevin bought $42,613 worth of shares (7,411 units at $5.75), increasing direct ownership by 2% to 372,338 units (SEC Form 4)

      4 - MEDICAL PROPERTIES TRUST INC (0001287865) (Issuer)

      3/6/25 4:37:27 PM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate
    • Director Pitman Elizabeth N bought $48,603 worth of shares (8,087 units at $6.01), increasing direct ownership by 12% to 76,740 units (SEC Form 4)

      4 - MEDICAL PROPERTIES TRUST INC (0001287865) (Issuer)

      9/19/24 6:01:37 PM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate

    $MPW
    Leadership Updates

    Live Leadership Updates

    See more
    • Super Micro Computer and Deckers Outdoor Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

      NEW YORK, March 1, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 18, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed

      3/1/24 6:47:00 PM ET
      $AIT
      $AL
      $APPS
      $ARCH
      Industrial Specialties
      Consumer Discretionary
      Diversified Commercial Services
      Multi-Sector Companies
    • Medical Properties Trust, Inc.: Please contact the Portnoy Law Firm to recover your losses; November 28, 2023 deadline

      Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, Nov. 13, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Medical Properties Trust, Inc. ("MPW" or the "Company") (NYSE:MPW) investors that a lawsuit filed on behalf of investors that purchased MPW during the class period. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. In May 2023

      11/13/23 7:04:19 PM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate
    • Medical Properties Trust, Inc.: Please contact the Portnoy Law Firm to recover your losses; November 28, 2023 deadline

      Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, Oct. 25, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Medical Properties Trust, Inc. ("MPW" or the "Company") (NYSE:MPW) investors that a lawsuit filed on behalf of investors that purchased MPW during the class period. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. In May 2023, MPW,

      10/25/23 5:36:30 PM ET
      $MPW
      Real Estate Investment Trusts
      Real Estate